ABT-493
Showing 376 - 384 of 384
Sarcoma, Soft Tissue Trial in United States (ABT-510 - Thrombospondin-1 mimetic)
Completed
- Sarcoma, Soft Tissue
- ABT-510 - Thrombospondin-1 mimetic
-
Scottsdale, Arizona
- +4 more
Nov 28, 2007
Lymphoma, Non-Hodgkin, Hodgkin's Lymphoma Trial in United States (ABT-510 - Thrombospondin-1 Mimetic)
Completed
- Lymphoma, Non-Hodgkin
- Hodgkin's Lymphoma
- ABT-510 - Thrombospondin-1 Mimetic
-
Phoenix, Arizona
- +13 more
Aug 13, 2007
Carcinoma, Renal Cell Trial in Netherlands, United States (ABT-510/Thrombospondin-1 mimetic)
Completed
- Carcinoma, Renal Cell
- ABT-510/Thrombospondin-1 mimetic
-
Scottsdale, Arizona
- +17 more
Aug 13, 2007
NSCLC Trial in United States (ABT-510/Thrombospondin-1 mimetic, Carboplatin/Taxol)
Terminated
- Carcinoma, Non-Small-Cell Lung
- ABT-510/Thrombospondin-1 mimetic
- Carboplatin/Taxol
-
Miami, Florida
- +3 more
Aug 10, 2007
HIV Trial in New York (Lopinavir/ritonavir, Efavirenz, Lamivudine)
Completed
- HIV Infections
- Lopinavir/ritonavir
- +3 more
-
New York, New YorkAaron Diamond AIDS Research Center - Rockefeller University
Jul 26, 2006
HIV Trial in San Francisco (Lopinavir/Ritonavir, Efavirenz)
Completed
- HIV Infections
-
San Francisco, CaliforniaViRx Inc
Jun 23, 2005